Norepinephrine-dopamine interactions in the prefrontal cortex and the ventral tegmental area: relevance to mental diseases.
Tassin
J P
JP
INSERM U.114, Collège de France, Paris, France.
D000320:Adrenergic Fibers / Q000502:physiology; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D001523:Mental Disorders / Q000503:physiopathology*; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D009638:Norepinephrine / Q000502:physiology*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology; D017397:Prefrontal Cortex / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D051381:Rats; D017447:Receptors, Dopamine D1 / Q000502:physiology; D013681:Tegmentum Mesencephali / Q000502:physiology* / Q000503:physiopathology
D001552:Benzazepines; D017447:Receptors, Dopamine D1; D004298:Dopamine; D009638:Norepinephrine